Clinical outcomes of a real‐world prospective study using Dexcom <scp>ONE</scp> continuous glucose monitoring in people with diabetes treated with two or more insulin injections per day
Real-world Dexcom ONE use was associated with clinically significant reductions in mean HbA1c after 6 months, along with meaningful improvements in participant-reported outcomes. CGM-derived outcomes also improved, with the possibility of there being greater improvement than could be captured in this study. These findings support expanding access to this real-time CGM system.
Authors
- Laura Currin (ORCID: https://orcid.org/0000-0003-4280-1650)
- S. Hudson
- Hoda Nemat (ORCID: https://orcid.org/0000-0003-3276-3953)
- Heydar Khadem (ORCID: https://orcid.org/0000-0002-6878-875X)
- Daisy Elliott (ORCID: https://orcid.org/0000-0001-8143-9549)
- Chloe Husband
- Lucy Cardno
Institutions
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Sheffield (GB)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2025-01-28
- DOI
- https://doi.org/10.1111/dme.15519
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Dexcom